US4013652A
(en)
*
|
1972-06-19 |
1977-03-22 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzoxazine
|
US4183936A
(en)
*
|
1972-06-19 |
1980-01-15 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
US4115577A
(en)
*
|
1972-06-19 |
1978-09-19 |
Endo Laboratories, Inc. |
Pyridopyrrolobenzheterocycles
|
IT1119096B
(it)
*
|
1978-06-05 |
1986-03-03 |
Sankyo Co |
Derivati della benzotiazocina e della benzotiazonina particolarmente utili come medicamenti e procedimento per la loro preparazione
|
US4219550A
(en)
*
|
1978-11-09 |
1980-08-26 |
E. I. Du Pont De Nemours And Company |
Cis- and trans- octahydropyridopyrrolobenzheterocycles
|
JPH02180885A
(ja)
*
|
1988-09-01 |
1990-07-13 |
Glaxo Group Ltd |
ラクタム誘導体
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
EP0380155A1
(en)
*
|
1989-01-19 |
1990-08-01 |
Duphar International Research B.V |
8,9-Annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
|
US6552017B1
(en)
|
1999-06-15 |
2003-04-22 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
US6713471B1
(en)
*
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
US6849619B2
(en)
*
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
KR20030070590A
(ko)
|
2000-12-20 |
2003-08-30 |
브리스톨-마이어스스퀴브컴파니 |
세로토닌 효능제 및 길항제로서 치환된 피롤로퀴놀린 및피리도퀴놀린
|
BR0116347A
(pt)
|
2000-12-20 |
2004-07-06 |
Bristol Myers Squibb Pharma Co |
Derivados pirazinoquinoxalina substituìdos como agonistas e antagonistas do receptor de serotonina
|
BR0116429A
(pt)
*
|
2000-12-20 |
2006-05-09 |
Bristol Myers Squibb Co |
piridoindóis substituìdos como agonistas e antagonistas da serotonina
|
CA2460126A1
(en)
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
AU2003303210A1
(en)
*
|
2002-12-19 |
2004-07-14 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
CA2679754C
(en)
|
2007-03-12 |
2018-08-07 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
WO2011044134A1
(en)
|
2009-10-05 |
2011-04-14 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
|
EP2668191A4
(en)
|
2011-01-19 |
2014-08-20 |
Albany Molecular Res Inc |
BENZOFURO- [3,2-C-] PYRIDINES AND RELATED ANALOGS AS SEROTONIN-SUBTYPE-6 (5-HT6) MODULATORS FOR THE TREATMENT OF ADIPOSITAS, METABOLISM SYNDROME, COGNITION AND SCHIZOPHRENIA
|
JP2015514135A
(ja)
|
2012-04-14 |
2015-05-18 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規組成物および方法
|
EP2968320B1
(en)
|
2013-03-15 |
2020-11-11 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
KR102372145B1
(ko)
*
|
2013-12-03 |
2022-03-07 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
SI3125893T1
(sl)
|
2014-04-04 |
2023-12-29 |
Intra-Cellular Therapies, Inc. |
Devterirani heterociklični zliti gama-karbolini kot antagonisti receptorjev 5-HT2A
|
RU2016143091A
(ru)
|
2014-04-04 |
2018-05-08 |
Интра-Селлулар Терапиз, Инк. |
Органические соединения
|
CN108883111B
(zh)
|
2016-01-26 |
2021-10-08 |
细胞内治疗公司 |
有机化合物
|
CA3016353C
(en)
|
2016-03-25 |
2021-04-27 |
Intra-Cellular Therapies, Inc. |
Deuterated fused heterocycle gamma-carbolines and compositions thereof useful in the treatment of nervous system disorders
|
EP3436083A4
(en)
|
2016-03-28 |
2019-11-27 |
Intra-Cellular Therapies, Inc. |
NEW COMPOSITIONS AND METHODS
|
EP3436455A4
(en)
|
2016-03-28 |
2019-09-04 |
Intra-Cellular Therapies, Inc. |
NOVEL SALTS AND CRYSTALS
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
EP3525763A4
(en)
|
2016-10-12 |
2020-06-17 |
Intra-Cellular Therapies, Inc. |
AMORPHE FIXED DISPERSIONS
|
EP3562484B1
(en)
|
2016-12-29 |
2021-08-25 |
Intra-Cellular Therapies, Inc. |
Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
|
US10961245B2
(en)
|
2016-12-29 |
2021-03-30 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
|
KR20220066988A
(ko)
|
2017-03-24 |
2022-05-24 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 조성물 및 방법
|
CN111093664B
(zh)
|
2017-07-26 |
2023-06-02 |
细胞内治疗公司 |
有机化合物
|
CN111093665A
(zh)
|
2017-07-26 |
2020-05-01 |
细胞内治疗公司 |
有机化合物
|
CN110831941A
(zh)
|
2018-06-11 |
2020-02-21 |
细胞内治疗公司 |
取代的杂环稠合的γ-咔啉类化合物合成
|
AU2019331490A1
(en)
|
2018-08-31 |
2021-03-18 |
Intra-Cellular Therapies, Inc. |
Novel methods
|